Table 4.
Completion rate for questionnaire items shared in the three national self-reporting ADR systems
| Questionnaire items | na |
|---|---|
| Persons who have experienced ADRs | |
| Reporter’s own self | 542 |
| Others except the reporter | 72 |
| Sex | 39 |
| Age | 72 |
| ADRs appeared | |
| Symptoms or signs for the suspected ADR that the subject experienced, and the severity of these ADRs | 589 |
| Start time when the ADR appeared | 0 |
| Suspected medicines for ADRs | |
| Brand name of the medicine that the reporter regarded as the suspected medicine | 614b |
| Start day of the medication | 0 |
| Diseases or conditions for which the medicine was used | 434b |
| Outcome of ADRs | 3 |
| Whether the reporter or their family members experienced ADRs similar to the current ADR in the pastc | 6 |
| Brand name of the medicine | 6 |
| Symptoms or signs of ADRs | 6 |
| Lifestyle-related descriptionsc | |
| Allergic constitution | 2 |
| Smoking | 2 |
| Alcohol drinking | 2 |
Notes:
a
The number of inquiries within 614 questions including ADR descriptions.
b
The names of medicines or diseases/conditions described in the inquiries were not necessarily completed for all inquiries, but if they were at least partially described, the inquiry was considered to have names of the medicine or disease/condition. cSubjects spontaneously described multiple items so as to fill these virtual questions.
Abbreviation: ADR, adverse drug reaction.